These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11133752)

  • 1. Posttranslational modifications of recombinant myotube-synthesized human factor IX.
    Arruda VR; Hagstrom JN; Deitch J; Heiman-Patterson T; Camire RM; Chu K; Fields PA; Herzog RW; Couto LB; Larson PJ; High KA
    Blood; 2001 Jan; 97(1):130-8. PubMed ID: 11133752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-mediated gene transfer for hemophilia.
    High KA
    Ann N Y Acad Sci; 2001 Dec; 953():64-74. PubMed ID: 11795424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter.
    Hagstrom JN; Couto LB; Scallan C; Burton M; McCleland ML; Fields PA; Arruda VR; Herzog RW; High KA
    Blood; 2000 Apr; 95(8):2536-42. PubMed ID: 10753832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus-mediated gene transfer for hemophilia B.
    High KA
    Int J Hematol; 2002 Nov; 76(4):310-8. PubMed ID: 12463593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.
    Arruda VR; Schuettrumpf J; Herzog RW; Nichols TC; Robinson N; Lotfi Y; Mingozzi F; Xiao W; Couto LB; High KA
    Blood; 2004 Jan; 103(1):85-92. PubMed ID: 12969984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle as a target for supplementary factor IX gene transfer.
    Hoffman BE; Dobrzynski E; Wang L; Hirao L; Mingozzi F; Cao O; Herzog RW
    Hum Gene Ther; 2007 Jul; 18(7):603-13. PubMed ID: 17594244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor IX variants improve gene therapy efficacy for hemophilia B.
    Schuettrumpf J; Herzog RW; Schlachterman A; Kaufhold A; Stafford DW; Arruda VR
    Blood; 2005 Mar; 105(6):2316-23. PubMed ID: 15550487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.
    Manno CS; Chew AJ; Hutchison S; Larson PJ; Herzog RW; Arruda VR; Tai SJ; Ragni MV; Thompson A; Ozelo M; Couto LB; Leonard DG; Johnson FA; McClelland A; Scallan C; Skarsgard E; Flake AW; Kay MA; High KA; Glader B
    Blood; 2003 Apr; 101(8):2963-72. PubMed ID: 12515715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
    Chen L; Perlick H; Morgan RA
    Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
    Manno CS; Pierce GF; Arruda VR; Glader B; Ragni M; Rasko JJ; Ozelo MC; Hoots K; Blatt P; Konkle B; Dake M; Kaye R; Razavi M; Zajko A; Zehnder J; Rustagi PK; Nakai H; Chew A; Leonard D; Wright JF; Lessard RR; Sommer JM; Tigges M; Sabatino D; Luk A; Jiang H; Mingozzi F; Couto L; Ertl HC; High KA; Kay MA
    Nat Med; 2006 Mar; 12(3):342-7. PubMed ID: 16474400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX.
    Jorgensen MJ; Cantor AB; Furie BC; Brown CL; Shoemaker CB; Furie B
    Cell; 1987 Jan; 48(2):185-91. PubMed ID: 3802193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector.
    Liu YL; Mingozzi F; Rodriguéz-Colôn SM; Joseph S; Dobrzynski E; Suzuki T; High KA; Herzog RW
    Hum Gene Ther; 2004 Aug; 15(8):783-92. PubMed ID: 15319035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site.
    Bristol JA; Furie BC; Furie B
    J Biol Chem; 1993 Apr; 268(10):7577-84. PubMed ID: 8463288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propeptide mutations on post-translational processing of factor IX. Evidence that beta-hydroxylation and gamma-carboxylation are independent events.
    Rabiet MJ; Jorgensen MJ; Furie B; Furie BC
    J Biol Chem; 1987 Nov; 262(31):14895-8. PubMed ID: 3667614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.
    Herzog RW; Hagstrom JN; Kung SH; Tai SJ; Wilson JM; Fisher KJ; High KA
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5804-9. PubMed ID: 9159155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells.
    Kaufman RJ; Wasley LC; Furie BC; Furie B; Shoemaker CB
    J Biol Chem; 1986 Jul; 261(21):9622-8. PubMed ID: 3733688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of AAV-CMV-F.IX And AAV-EF1alpha-F.IX in gene therapy for hemophilia B.
    Wiwanitkit V
    Hum Gene Ther; 2007 Feb; 18(2):89-92. PubMed ID: 17266422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.
    Wang L; Takabe K; Bidlingmaier SM; Ill CR; Verma IM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3906-10. PubMed ID: 10097136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.